Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lemberger

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Clinical Pharmacology and Therapeutics|September 1, 1975
Effects of marihuana combined with secobarbitalW S Dalton, R Martz, L Lemberger, et al.
Clinical Pharmacology and Therapeutics|December 1, 1976
Influence of cannabidiol on secobarbital effects and plasma kineticsW S Dalton, R Martz, B E Rodda, et al.
Neuropharmacology|September 1, 1972
Induction of adrenal tyrosine hydroxylase in organ cultureS D Silberstein, L Lemberger, D C Klein, et al.
Life Sciences|January 1, 1988
Pressor responses to tyramine and norepinephrine after subchronic administration of fluoxetine to manD J Bowsher, H Rowe, N A Farid, et al.
Life Sciences|August 15, 1976
Tetrahydrocannabinol (THC): metabolism and subjective effectsR Stillman, M Galanter, L Lemberger, et al.
Clinical Pharmacology and Therapeutics|April 1, 1988
The effect of fluoxetine on the pharmacokinetics and psychomotor responses of diazepamL Lemberger, H Rowe, J C Bosomworth, et al.
Clinical Pharmacology and Therapeutics|June 1, 1985
Effect of fluoxetine on psychomotor performance, physiologic response, and kinetics of ethanolL Lemberger, H Rowe, R F Bergstrom, et al.
International Clinical Psychopharmacology|January 1, 1993
The effects of renal and hepatic disease on the pharmacokinetics, renal tolerance, and risk-benefit profile of fluoxetineR F Bergstrom, C M Beasley, N B Levy, et al.
Clinical Pharmacology and Therapeutics|September 1, 1976
Effects of marihuana-dextroamphetamine combinationM A Evans, R Martz, B E Rodda, et al.
Cancer Treatment Reviews|December 1, 1982
Pharmacokinetics, metabolism and drug-abuse potential of nabiloneL Lemberger, A Rubin, R Wolen, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Clinical Pharmacology and Therapeutics|September 1, 1975
Effects of marihuana combined with secobarbitalW S Dalton, R Martz, L Lemberger, et al.
Clinical Pharmacology and Therapeutics|December 1, 1976
Influence of cannabidiol on secobarbital effects and plasma kineticsW S Dalton, R Martz, B E Rodda, et al.
Neuropharmacology|September 1, 1972
Induction of adrenal tyrosine hydroxylase in organ cultureS D Silberstein, L Lemberger, D C Klein, et al.
Life Sciences|January 1, 1988
Pressor responses to tyramine and norepinephrine after subchronic administration of fluoxetine to manD J Bowsher, H Rowe, N A Farid, et al.
Life Sciences|August 15, 1976
Tetrahydrocannabinol (THC): metabolism and subjective effectsR Stillman, M Galanter, L Lemberger, et al.
Clinical Pharmacology and Therapeutics|April 1, 1988
The effect of fluoxetine on the pharmacokinetics and psychomotor responses of diazepamL Lemberger, H Rowe, J C Bosomworth, et al.
Clinical Pharmacology and Therapeutics|June 1, 1985
Effect of fluoxetine on psychomotor performance, physiologic response, and kinetics of ethanolL Lemberger, H Rowe, R F Bergstrom, et al.
International Clinical Psychopharmacology|January 1, 1993
The effects of renal and hepatic disease on the pharmacokinetics, renal tolerance, and risk-benefit profile of fluoxetineR F Bergstrom, C M Beasley, N B Levy, et al.
Clinical Pharmacology and Therapeutics|September 1, 1976
Effects of marihuana-dextroamphetamine combinationM A Evans, R Martz, B E Rodda, et al.
Cancer Treatment Reviews|December 1, 1982
Pharmacokinetics, metabolism and drug-abuse potential of nabiloneL Lemberger, A Rubin, R Wolen, et al.
Pageof 8